Your browser doesn't support javascript.
loading
Liraglutide treatment attenuates inflammation markers in the cardiac, cerebral and renal microvasculature in streptozotocin-induced diabetic rats.
Baylan, Umit; Korn, Amber; Emmens, Reindert W; Schalkwijk, Casper G; Niessen, Hans W M; Krijnen, Paul A J; Simsek, Suat.
Afiliação
  • Baylan U; Department of Pathology, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
  • Korn A; Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Emmens RW; Department of Pathology, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
  • Schalkwijk CG; Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Niessen HWM; Department of Pathology, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
  • Krijnen PAJ; Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Simsek S; Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Eur J Clin Invest ; 52(9): e13807, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35488737

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Liraglutida Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Liraglutida Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article